Association between primary sclerosing cholangitis and the risk of colorectal cancer: A two-sample Mendelian randomization study

Zhenqi LI; Ning DU; Hongyang He

doi:10.3969/j.issn.1001-5256.2023.03.013

Volume 39 Issue 3

Mar. 2023

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(3): 567-572

PDF( 2338 KB)

Association between primary sclerosing cholangitis and the risk of colorectal cancer: A two-sample Mendelian randomization study

DOI: 10.3969/j.issn.1001-5256.2023.03.013

Zhenqi LI¹,
Ning DU^{1
,
,
,},
Hongyang He²

1.
School of Clinical Medicine, Dali University, Dali, Yunnan 671033, China
2.
First Department of General Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, China

Research funding:

Scientific Research Fund project of Yunnan Education Department (2022J0691)

More Information

Corresponding author: DU Ning, 489676174@qq.com (ORCID: 0000-0003-0517-2234)
Received Date: 2022-08-03
Accepted Date: 2022-10-01
Published Date: 2023-03-20

Abstract

Abstract

Objective To investigate the association between primary sclerosing cholangitis (PSC) and colorectal cancer (CRC) by using two-sample Mendelian randomization (TSMR). Methods The single nucleotide polymorphism (SNP) data associated with PSC and CRC were obtained from Finland Biobank and UK Biobank, respectively. A secondary data analysis was performed for all pooled data based on genome-wide association studies to select the genetic loci closely associated with PSC as instrumental variables, and TSMR was conducted by seven methods, i.e., Egger regression in Mendelian randomization, weighted median, inverse variance weighted (IVW) random effects model, maximum likelihood, linear weighted median, IVW radial method, and IVW fixed effects model. Odds ratio (OR) value was used to evaluate the causal relationship between PSC and the risk of CRC. Results There was a positive causal relationship between gene predicted PSC and CRC, and with the IVW fixed effects model as an example, genetically determined patients with PSC could increase the risk of CRC (OR=1.002 243, 95% confidence interval: 1.001 319-1.003 167). TSMR results showed no heterogeneity (P=0.87) or horizontal pleiotropy (P=0.95). The three instrumental variables selected for PSC were strong instrumental variables (F=11.86). Conclusion TSMR shows the genetic evidence for the association between PSC and the risk of CRC. Regardless of the presence or absence of inflammatory bowel disease, active enteroscopy screening among patients with PSC may help with the early identification and timely intervention of CRC.
- Primary Sclerosing Cholangitis,
- Colorectal Neoplasms,
- Mendelian Randomization Analysis

FullText(HTML)

References(22)

References

[1]	KARLSEN TH, FOLSERAAS T, THORBURN D, et al. Primary sclerosing cholangitis - a comprehensive review[J]. J Hepatol, 2017, 67(6): 1298-1323. DOI: 10.1016/j.jhep.2017.07.022.
[2]	VESTERHUS M, KARLSEN TH. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities[J]. J Gastroenterol, 2020, 55(6): 588-614. DOI: 10.1007/s00535-020-01681-z.
[3]	HENSON JB, HELZBERG JH, MUIR AJ. Patient-predicted outcomes are associated with quality of life in patients with primary sclerosing cholangitis[J]. Dig Dis Sci, 2022, 67(12): 5483-5492. DOI: 10.1007/s10620-022-07482-z.
[4]	de KRIJGER M, CARVALHO B, RAUSCH C, et al. Genetic profiling of colorectal carcinomas of patients with primary sclerosing cholangitis and inflammatory bowel disease[J]. Inflamm Bowel Dis, 2022, 28(9): 1309-1320. DOI: 10.1093/ibd/izac087.
[5]	ABBAS N, QURAISHI MN, TRIVEDI P. Emerging drugs for the treatment of primary sclerosing cholangitis[J]. Curr Opin Pharmacol, 2022, 62: 23-35. DOI: 10.1016/j.coph.2021.11.003.
[6]	NASSER-GHODSI N, MARA K, WATT KD. De novo colorectal and pancreatic cancer in liver-transplant recipients: identifying the higher-risk populations[J]. Hepatology, 2021, 74(2): 1003-1013. DOI: 10.1002/hep.31731.
[7]	SINGH S, EDAKKANAMBETH VARAYIL J, LOFTUS EV Jr, et al. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis[J]. Liver Transpl, 2013, 19(12): 1361-1369. DOI: 10.1002/lt.23741.
[8]	BRADEN B, HALLIDAY J, ARYASINGHA S, et al. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis[J]. Clin Gastroenterol Hepatol, 2012, 10(3): 303-308. DOI: 10.1016/j.cgh.2011.10.020.
[9]	XIE Y, CHEN X, DENG M, et al. Causal linkage between inflammatory bowel disease and primary sclerosing cholangitis: a two-sample mendelian randomization analysis[J]. Front Genet, 2021, 12: 649376. DOI: 10.3389/fgene.2021.649376.
[10]	LUNDBERG BÅVE A, BERGQUIST A, BOTTAI M, et al. Increased risk of cancer in patients with primary sclerosing cholangitis[J]. Hepatol Int, 2021, 15(5): 1174-1182. DOI: 10.1007/s12072-021-10214-6.
[11]	FUNG BM, LINDOR KD, TABIBIAN JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies[J]. World J Gastroenterol, 2019, 25(6): 659-671. DOI: 10.3748/wjg.v25.i6.659.
[12]	ROMPIANESI G, RAVIKUMAR R, JOSE S, et al. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients[J]. Liver Int, 2019, 39(2): 353-360. DOI: 10.1111/liv.13947.
[13]	KOMAKI Y, KOMAKI F, MICIC D, et al. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis[J]. Gastrointest Endosc, 2017, 86(1): 93-104.e5. DOI: 10.1016/j.gie.2016.12.009.
[14]	GOSSARD AA, GORES GJ. Primary sclerosing cholangitis: what the gastroenterologist and hepatologist needs to know[J]. Clin Liver Dis, 2017, 21(4): 725-737. DOI: 10.1016/j.cld.2017.06.004.
[15]	SHAH SC, TEN HOVE JR, CASTANEDA D, et al. High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease[J]. Clin Gastroenterol Hepatol, 2018, 16(7): 1106-1113.e3. DOI: 10.1016/j.cgh.2018.01.023.
[16]	HORSLEY-SILVA JL, RODRIGUEZ EA, FRANCO DL, et al. An update on cancer risk and surveillance in primary sclerosing cholangitis[J]. Liver Int, 2017, 37(8): 1103-1109. DOI: 10.1111/liv.13354.
[17]	TRIVEDI PJ, CROTHERS H, MYTTON J, et al. Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age[J]. Gastroenterology, 2020, 159(3): 915-928. DOI: 10.1053/j.gastro.2020.05.049.
[18]	LOFTUS EV, SANDBORN WJ, TREMAINE WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis[J]. Gastroenterology, 1996, 110(2): 432-440. DOI: 10.1053/gast.1996.v110.pm8566590.
[19]	ADAMOWICZ M, STUKAN I, MILKIEWICZ P, et al. Modulation of mismatch repair and the SOCS1/p53 axis by microRNA-155 in the colon of patients with primary sclerosing cholangitis[J]. Int J Mol Sci, 2022, 23(9): 4905. DOI: 10.3390/ijms23094905.
[20]	VESTERHUS M, KARLSEN TH. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities[J]. J Gastroenterol, 2020, 55(6): 588-614. DOI: 10.1007/s00535-020-01681-z.
[21]	SAFFIOTI F, GURUSAMY KS, HAWKINS N, et al. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis[J]. Cochrane Database Syst Rev, 2017, 3(3): CD011343. DOI: 10.1002/14651858.CD011343.pub2.
[22]	JI SG, JURAN BD, MUCHA S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease[J]. Nat Genet, 2017, 49(2): 269-273. DOI: 10.1038/ng.3745.

Relative Articles

[1]	Rongjie LI, Yi PENG, Xiaolong TANG, Decai ZHANG, Shaojun LIU. Establishment of a modified BISAP scoring system and its clinical significance in the early diagnosis and prognostic evaluation of severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(10): 2432-2442. doi: 10.3969/j.issn.1001-5256.2023.10.022
[2]	Xiaoping ZOU. Advances in endoscopic retrograde cholangiopancreatography in diagnosis and treatment of pancreatic diseases in children[J]. Journal of Clinical Hepatology, 2022, 38(12): 2687-2692. doi: 10.3969/j.issn.1001-5256.2022.12.002
[3]	Lijian YANG, Honglai XU, Yuelong HUANG, Xueli LI, Xiubing CHEN. Complete rupture of the pancreas and duodenum caused by car accident in children: A case report[J]. Journal of Clinical Hepatology, 2021, 37(11): 2653-2654. doi: 10.3969/j.issn.1001-5256.2021.11.035
[4]	Zhou Yan, Ning Bo. Application of abnormal cell-free DNA methylation in pancreatic juice in the early diagnosis of pancreatic cancer[J]. Journal of Clinical Hepatology, 2020, 36(9): 2145-2148. doi: 10.3969/j.issn.1001-5256.2020.09.054
[5]	Zhang TingTing, Liu RuiXia, Yin ChengHong. Early diagnosis of acute pancreatitis in pregnancy[J]. Journal of Clinical Hepatology, 2020, 36(7): 1669-1672. doi: 10.3969/j.issn.1001-5256.2020.07.050
[6]	Zhang YanFang, Guo YuMing, Niu Ming, Ge FeiLin, Jing Jing, Zhu Yun, Zhu ShiShu, Han ZiXin, Wang JiaBo, Liu ShiJing, Xiao XiaoHe. Drug-induced liver injury in children:An analysis of medication and clinical features[J]. Journal of Clinical Hepatology, 2019, 35(3): 579-584. doi: 10.3969/j.issn.1001-5256.2019.03.025
[7]	Yan YanYan, Xie XinBao, Wang JianShe. An excerpt of management of acute pancreatitis in the pediatric population: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee（2018）[J]. Journal of Clinical Hepatology, 2018, 34(5): 982-986. doi: 10.3969/j.issn.1001-5256.2018.05.011
[8]	Huang XinYu, Zhang QiuZan. An excerpt of NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children[J]. Journal of Clinical Hepatology, 2017, 33(4): 638-642. doi: 10.3969/j.issn.1001-5256.2017.04.007
[9]	Li Jing, Qi LingLi, Wu Jie. Research advances in the diagnosis of nonalcoholic fatty liver disease in children[J]. Journal of Clinical Hepatology, 2017, 33(10): 2025-2029. doi: 10.3969/j.issn.1001-5256.2017.10.038
[10]	Wu Jie, Liu YuFei, Kong WenWen, Wang ChaoXia. Advances in the diagnosis and treatment of pediatric acute pancreatitis[J]. Journal of Clinical Hepatology, 2017, 33(6): 1196-1200. doi: 10.3969/j.issn.1001-5256.2017.06.039
[11]	Sun XueFeng, Yuan XinYu. Imaging diagnosis of liver tumors in children[J]. Journal of Clinical Hepatology, 2016, 32(12): 2282-2288. doi: 10.3969/j.issn.1001-5256.2016.12.011
[12]	Liu Xu, Guo XiaoZhong. Early diagnosis of pancreatic cancer[J]. Journal of Clinical Hepatology, 2016, 32(5): 864-866. doi: 10.3969/j.issn.1001-5256.2016.05.008
[13]	Ni Rui, Wang ManCai, Zhang YouCheng. Diagnosis of pancreatic cancer based on biological information of saliva: an analysis of current status[J]. Journal of Clinical Hepatology, 2015, 31(5): 678-680. doi: 10.3969/j.issn.1001-5256.2015.05.010
[14]	Gan Yu, Dong Yi, Zhang HongFei, Xu ZhiQiang, Chen DaWei, Wang LiMin, Wang FuChuan, Yan JianGuo, Zhu ShiShu. Clinical characteristics and outcomes of drug-induced liver injury in children: a study of 184 cases[J]. Journal of Clinical Hepatology, 2015, 31(8): 1244-1247. doi: 10.3969/j.issn.1001-5256.2015.08.015
[15]	Lu Yi, Yu Hui. Discussion on idiosyncratic drug-induced liver injury in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1215-1217. doi: 10.3969/j.issn.1001-5256.2015.08.008
[16]	Guo Jing, Sun Mei. Diagnosis and differential diagnosis of diseases with elevated aminotransferase in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1230-1234. doi: 10.3969/j.issn.1001-5256.2015.08.012
[17]	Guo XiaoZhong, Liu Xu. Discussion of difficult problems of early diagnosis of pancreatic cancer[J]. Journal of Clinical Hepatology, 2014, 30(8): 734-736. doi: 10.3969/j.issn.1001-5256.2014.08.008
[18]	Lu Yi, Wang JianShe. Diagnosis of Wilson's disease in children[J]. Journal of Clinical Hepatology, 2012, 28(12): 907-910.
[19]	Li ZhaoShen. Status and prospects of early diagnosis of pancreatic cancer[J]. Journal of Clinical Hepatology, 2010, 26(5): 451-453+458.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(5) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (1217) PDF downloads(184)

Association between primary sclerosing cholangitis and the risk of colorectal cancer: A two-sample Mendelian randomization study

DOI: 10.3969/j.issn.1001-5256.2023.03.013

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Association between primary sclerosing cholangitis and the risk of colorectal cancer: A two-sample Mendelian randomization study

DOI: 10.3969/j.issn.1001-5256.2023.03.013

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content